CoChat

Sodium‐glucose co‐transporter‐2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: Arandomized, open‐label, 3‐arm parallel comparative, exploratory study

Open access
Yabe, Daisuke, Iwasaki, Masahiro, Kuwata, Hitoshi, Haraguchi, Takuya, Hamamoto, Yoshiyuki, Kurose, Takeshi, Sumita, Kiminobu, Yamazato, Hitoshi, Kanada, Shigeto, Seino, Yutaka · 2017 · Diabetes, Obesity and Metabolism
Cited by 67

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

This study investigated the safety and efficacy of the sodium‐glucose co‐transporter‐2 ( SGLT2 ) inhibitor luseogliflozin with differing carbohydrate intakes in J apanese individuals with type 2 diabetes ( T2D ). Participants were randomly assigned to 3 carbohydrate‐adjusted meals for 14 days (days 1‐14; a high carbohydrate [ HC ; 55% total energy carbohydrate] and high glycaemic index [ HGI ] meal; an HC [55% total energy carbohydrate] and low glycaemic index [ LGI ] meal; or a low carbohydrate [ LC ; 40% total energy carbohydrate] and HGI meal). All participants received luseogliflozin for the last 7 days (days 8‐14), continuous glucose monitoring ( CGM ) before and after luseogliflozin treatment (days 5‐8 and days 12‐15) and blood tests on days 1, 8 and 15. Luseogliflozin significantly decreased the area under the curve and mean of CGM values in all 3 groups similarly. Fasting plasma glucose, insulin and glucagon were similar at all time points. Ketone bodies on day 15 were significantly higher in the LC‐HGI group compared with the HC‐HGI and HC‐LGI groups. In conclusion, luseogliflozin has similar efficacy and safety in J apanese people with T2D when meals contain 40% to 55% total energy carbohydrate, but a strict LC diet on this class of drug should be avoided to prevent SGLT2 inhibitor‐associated diabetic ketoacidosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12848

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Yabe, D., Iwasaki, M., Kuwata, H., Haraguchi, T., Hamamoto, Y., Kurose, T., Sumita, K., Yamazato, H., Kanada, S., & Seino, Y.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2017-02-21
Volume
19
Issue
5
Pages
739-743
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2593546451
Cited by
67
References
8
FWCI
9.53
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.